Back to CLDX Stock Lookup

Celldex Therapeutics (CLDX) – Company Press Releases

Dec 18, 2014 08:01 AM Celldex Therapeutics Announces Appointment to Board of Directors
Dec 15, 2014 04:01 PM Celldex Announces Completion of Enrollment in Phase 3 Study of Rindopepimut in Frontline Glioblastoma
Dec 4, 2014 04:01 PM Celldex Therapeutics Initiates a Phase 2 Study of Glembatumumab Vedotin in Patients with Advanced Melanoma
Dec 4, 2014 04:01 PM Celldex Therapeutics Initiates a Phase 2 Study of Glembatumumab Vedotin in Patients with Advanced Melanoma
Nov 14, 2014 03:35 PM Interim Update from Randomized Phase 2 ReACT Study of Rindopepimut in Recurrent Bevacizumab-naive Glioblastoma Demonstrates Statistically Significant Survival Benefit
Nov 10, 2014 04:05 PM Oncothyreon and Celldex Therapeutics Announce Initiation of Combination Immunotherapy Clinical Trial of ONT-10 and Varlilumab
Nov 7, 2014 10:01 AM Celldex Presents Varlilumab Proof of Concept Data at SITC Annual Meeting 2014
Nov 7, 2014 10:01 AM Celldex Presents Varlilumab Proof of Concept Data at SITC Annual Meeting 2014
Nov 4, 2014 04:01 PM Celldex Reports Third Quarter 2014 Results
Nov 4, 2014 04:01 PM Celldex Reports Third Quarter 2014 Results
Nov 3, 2014 07:01 AM Celldex Therapeutics Announces Upcoming Presentations of Rindopepimut Data at 19th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO)
Sep 30, 2014 04:08 PM Celldex Announces Publication of Glembatumumab Vedotin Phase 1/2 Studies in the Journal of Clinical Oncology
Sep 25, 2014 08:05 AM Celldex Therapeutics Initiates Pilot Study of CDX-301 in Allogeneic Hematopoietic Stem Cell Transplantation
Sep 25, 2014 08:05 AM Celldex Therapeutics Initiates Pilot Study of CDX-301 in Allogeneic Hematopoietic Stem Cell Transplantation
Sep 3, 2014 02:00 PM Celldex Announces Upcoming Presentation at the Morgan Stanley Healthcare Conference
Aug 6, 2014 04:01 PM Celldex Reports Second Quarter 2014 Results
Jul 30, 2014 08:03 AM Celldex Therapeutics Announces Senior Leadership Promotions
Jul 18, 2014 08:03 AM Celldex to Report Second Quarter 2014 Financial Results and Host Corporate 2014 Objectives Update Call
May 28, 2014 11:00 AM Celldex Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference
May 14, 2014 05:01 PM Celldex Therapeutics Announces Varlilumab (CDX-1127) Phase 1 Clinical Data to be Presented at ASCO Annual Meeting 2014
May 2, 2014 11:45 AM Celldex to Present at Two Upcoming Investor Conferences

Back to CLDX Stock Lookup